Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.217
+0.008 (3.93%)
Apr 29, 2026, 9:37 AM EDT - Market open
Aspire Biopharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -24.48 | -1.31 | -0.36 | -0.6 |
| Other Amortization | 8.02 | - | - | - |
| Stock-Based Compensation | 14.13 | - | - | - |
| Other Operating Activities | -3.13 | - | - | - |
| Change in Inventory | -0.25 | - | - | - |
| Change in Accounts Payable | -0.32 | 0.25 | 0.05 | 0.1 |
| Change in Other Net Operating Assets | 1.11 | 0.8 | 0.32 | 0.35 |
| Operating Cash Flow | -4.92 | -0.27 | 0.01 | -0.14 |
| Sale (Purchase) of Intangibles | - | - | - | -4.9 |
| Investing Cash Flow | - | - | - | -4.9 |
| Short-Term Debt Issued | 10.3 | - | - | - |
| Total Debt Issued | 10.3 | - | - | - |
| Short-Term Debt Repaid | -3.73 | - | - | - |
| Total Debt Repaid | -3.73 | - | - | - |
| Net Debt Issued (Repaid) | 6.57 | - | - | - |
| Issuance of Common Stock | 0.81 | 0.26 | - | 1 |
| Other Financing Activities | -1.45 | - | - | 3.85 |
| Financing Cash Flow | 5.92 | 0.26 | - | 4.85 |
| Net Cash Flow | 1 | -0.01 | 0.01 | -0.19 |
| Cash Interest Paid | 0.04 | - | - | - |
| Levered Free Cash Flow | 15.39 | -0.68 | -0.19 | - |
| Unlevered Free Cash Flow | 12.7 | -0.62 | -0.19 | - |
| Change in Working Capital | 0.53 | 1.04 | 0.37 | 0.45 |
Source: S&P Capital IQ. Standard template.
Financial Sources.